Abstract

References
1.American Cancer Society . Cancer Facts and Figures, 2010. Atlanta, GA : American Cancer Society ; 2010 .
2.
Young
R.C.
,
Chabner
B.A.
,
Hubbard
S.P.
. Advanced ovarian adenocarcinoma: a prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med. 1978 ; 299 (23 ): 1261 –1266 .
3.
Armstrong
D.K.
,
Bundy
B.
,
Wenzel
L.
. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006 ; 354 (1 ): 34 –43 .
4.
Berchuck
A.
,
Iversen
E.S.
,
Luo
J.
. Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome. Clin Cancer Res. 2009 ; 15 (7 ): 2448 –2455 .
5.
Vergote
I.
,
Tropé
C.G.
,
Amant
F.
. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010 ; 363 (10 ): 943 –953 .
